30 July 2018
Visiongain’ has launched a new pharma report 3D Printing for Healthcare World Market Report: Forecasts by Products (Dental Products, Medical Implants, Bio-Printing, Others) By Technology (Hardware, Software, Services) & Analysis of Opportunities in Personalised Medicine, Medical Devices, Tailor Made Prosthetics, Orthopaedic Implants & Drugs
The 3D printing for healthcare market is in an emerging state due to the large number of developments by the leading market players and high adoption rate of 3D printing for healthcare. The key players of the world 3D printing for healthcare market are employing novel concepts and ideas, improving manufacturing techniques, and improving the current set of products, besides enhancing their profitability to gain a competitive edge over other market players. Therefore, key players have adopted acquisition & product launch and development as the key developmental strategies to cater to the changing demands of end users.
The lead analyst of the report commented “The demand for 3D printed products and solutions in healthcare will increase throughout the forecast period. The ability to create patient-specific solutions across a variety of healthcare applications offers a number of advantages in terms of both costs and outcomes for patients, payers and providers. Therefore, implementation of 3D printing technology is being driven by healthcare providers who aim to improve quality of life for their patients whilst minimising costs, and by patients, whose improving knowledge and understanding of their treatment options ensures they demand a more personalised approach.”
Leading companies featured in the report include 3D Systems Inc., Arcam AB, Autodesk Inc., ExOne Company, H Intressenter AB, Optomec, Inc., Organovo Holdings, Inc., Ponoko Limited, Stratasys Ltd, Voxeljet AG
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 208 781 6953
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.
13 November 2020
Hypertensive is the most common disease around the world. However, number of people suffering from hypertensive has increased very significantly from last few years. Hypertensive can occur due to consumption of tobacco, too much salt (sodium) and little potassium in your diet, alcohol and to people being overweight or obese.
13 November 2020
The prevalence of bacterial diseases is significantly growing and expected to continuously rise over the forecast period. Number of bacterial diseases cases are increasing, like, bugs biting, including ticks, mosquitoes, lice and from an infected animal, contaminated food or water.
13 November 2020
Delivery of biologics through the transdermal route is anticipated to open new avenues for the manufacturers of topical drugs. Transdermal route provides appropriate and painless self-administration for patients. It overcomes frequent dosing administration, plasma level instability related to oral dosing and injections to uphold constant drug concentrations, and a drug with a short half-life can be supplied effortlessly.